AMANDA LEWIS: Open Payments
NPI 1518450105 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 65 payments from 15 companies in 2025. Trend: 2023 $1,436 · 2024 $1,671 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $313 |
| Novartis Pharmaceuticals Corporation | 11 | $201 |
| Medtronic, Inc. | 7 | $187 |
| PFIZER INC. | 6 | $119 |
| Merck Sharp & Dohme LLC | 6 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Lilly USA, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
Products named: FARXIGA, LEQVIO, AURORA EV-ICD MRI SURESCAN, ELIQUIS, VERQUVO, Kerendia, CAMZYOS, JARDIANCE.
Industry payments across LA — which companies pay providers there.
